116 3rd St SE
Cedar Rapids, Iowa 52401
North Liberty's KemPharm Receives Notice of Allowance for KP201
KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain, announced that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for its patent application entitled, "Benzoic Acid, Benzoic Acid Derivatives and Heteroaryl Carboxylic Acid Conjugates of Hydrocodone, Prodrugs, Methods of Making and Use Thereof."
Read the full story at www.icadgroup.com/news.
Daily Newsletters